Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Jack

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Histopathology|January 26, 2011
Changing practice in haematopathology: the impact of new technologies and better understanding of pathogenesisAndrew Jack
BMJ (Clinical Research Ed.)|January 19, 2013
Science minister lobbies health department over AstraZeneca drugAndrew Jack
Pathology|December 24, 2005
Organisation of neoplastic haematopathology services: a UK perspectiveAndrew Jack
BMJ (Clinical Research Ed.)|July 27, 2016
Open contracting for health servicesAndrew Jack
BMJ (Clinical Research Ed.)|July 21, 2007
Drug pricing: No cure, no costAndrew Jack
BMJ (Clinical Research Ed.)|June 21, 2008
Europe's drug companies are better than those in US in making drugs accessible to poor countriesAndrew Jack
BMJ (Clinical Research Ed.)|November 26, 2008
Generic substitution of drugs to be introduced in 2010Andrew Jack
BMJ (Clinical Research Ed.)|May 10, 2014
Tamiflu: "a nice little earner"Andrew Jack
BMJ (Clinical Research Ed.)|September 13, 2014
Peter Clark: public attitudes support a more favourable assessment for cancer treatmentsAndrew Jack
BMJ (Clinical Research Ed.)|August 24, 2010
MPs step in to save the UK's only mobile tuberculosis detection unitAndrew Jack
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Histopathology|January 26, 2011
Changing practice in haematopathology: the impact of new technologies and better understanding of pathogenesisAndrew Jack
BMJ (Clinical Research Ed.)|January 19, 2013
Science minister lobbies health department over AstraZeneca drugAndrew Jack
Pathology|December 24, 2005
Organisation of neoplastic haematopathology services: a UK perspectiveAndrew Jack
BMJ (Clinical Research Ed.)|July 27, 2016
Open contracting for health servicesAndrew Jack
BMJ (Clinical Research Ed.)|July 21, 2007
Drug pricing: No cure, no costAndrew Jack
BMJ (Clinical Research Ed.)|June 21, 2008
Europe's drug companies are better than those in US in making drugs accessible to poor countriesAndrew Jack
BMJ (Clinical Research Ed.)|November 26, 2008
Generic substitution of drugs to be introduced in 2010Andrew Jack
BMJ (Clinical Research Ed.)|May 10, 2014
Tamiflu: "a nice little earner"Andrew Jack
BMJ (Clinical Research Ed.)|September 13, 2014
Peter Clark: public attitudes support a more favourable assessment for cancer treatmentsAndrew Jack
BMJ (Clinical Research Ed.)|August 24, 2010
MPs step in to save the UK's only mobile tuberculosis detection unitAndrew Jack
Pageof 10